tirzepatide age approval 🚨 Diabetes News Update for Families 🚨 Big update in pediatric diabetes care 👇 Mounjaro (tirzepatide) is now approved for children and adolescents ages 10 and older with type 2 diabetes. This Lilly releases Zepbound® (tirzepatide) single-dose

Its a head and heart thing

Aim for at least 80 grams daily

Product Overview Product Name: Mounjaro KwikPen Strength: 10 mg Active Ingredient: Tirzepatide Dosage Form: Pre-filled Injection Pen Drug Class: GIP & GLP-1 Receptor Agonist Administration: Subcutaneous injection Uses of Mounjaro KwikPen 10 mg Injection Mounjaro KwikPen 10 mg Injection is used for: Type 2 Diabetes Mellitus improves blood sugar control Medical weight loss & obesity management Reducing appetite and food cravings Improving insulin sensitivity Supporting metabolic and cardiovascular health Weight management in patients with diabetes or insulin resistance It works by regulating insulin secretion, slowing gastric emptying, and increasing feelings of fullness

How Compounded GLP-1 Therapy Works: Appetite Regulation : Supports reduced hunger and improved portion control by acting on natural satiety pathways

One strength of this study was that it broke down the median weight loss after 1 year by peak dosage, which shows us that a higher dosage of injectable semaglutide was more efficacious overall than a smaller dose of tirzepatide